04Jun
Cannabis-Derived Ingredients in FDA-Regulated Products: More Questions than Answers at FDA’s May 2019 Public Hearing
As most folks with any interest in the burgeoning cannabidiol (CBD) industry likely know, on May 31, 2019, the Food and Drug Administration held a public hearing “to obtain scientific data and information about the safety, manufacturing, product...
By:
Mintz - Consumer Product Safety Viewpoints
Related
Neither rain nor sleet nor quarantine restrictions stop bid protests or our monthly roundup. Thus f...
Read More >
On June 28, 2019, Governor Mills signed LD 733, An Act To Promote Keeping Workers in Maine, into law...
Read More >
In recent years, there has been an ever-increasing number of public and private companies adopting e...
Read More >
In the latest installment of our bid protest spotlight (featured on Law360), we analyze three Govern...
Read More >
In a recent revenue ruling, the IRS stated that if a participant or a beneficiary doesn’t cash a di...
Read More >
On this episode of In-house Roundhouse, Rob DelPriore, Executive Vice President and General Counsel,...
Read More >